Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Generation of high-quality synthetic brain MRI data could be beneficial for advancing neuroimaging research, particularly when access to large-scale, labeled datasets is limited. In this work, we leverage a pretrained Diffusion Transformer (DiT) architecture to synthesize 3D mean diffusivity (MD) scalar maps from the Cam-CAN dataset. To adapt the DiT model—originally trained on 2D natural images—f...
Alzheimer’s disease (AD) is a progressive and debilitating neurodegenerative disease of the central nervous system, characterized by deterioration in cognitive function including extensive memory impairment. The hippocampus, a medial temporal lobe region, is a key orchestrator in the encoding and retrieval of memory and is believed to be one of the first regions to deteriorate in AD. In this work ...
Polygenic Risk Scores (PRS) are emerging tools for predicting an individual’s genetic risk for complex diseases. However, their usefulness in clinical...
Aberrant biomolecular condensates are implicated in multiple incurable neurological disorders, including Amyotrophic Lateral Sclerosis, Frontotemporal...
The brain’s connectome provides a powerful blueprint for designing efficient neural networks, yet the impact of incorporating its intricate, non-rando...
Alzheimer’s disease (AD) is a major global health concern, expected to affect 12.7 million Americans by 2050. Machine learning (ML) algorithms have be...
Single-omics approaches often provide a limited perspective on complex biological systems, whereas multi-omics integration enables a more comprehensiv...
Abnormal tau accumulation is a hallmark of neurodegenerative tauopathies such as Progressive Supranuclear Palsy (PSP). Traditional post-mortem assessm...
Alterations in metabolism, stress response, sleep, circadian rhythms, and neuroendocrine processes are key features of aging and neurodegeneration. Th...
Predicting symptom onset in genetic frontotemporal dementia (FTD) is crucial for advancing targeted interventions and clinical trial design. Brain cha...
Olfactory dysfunction is a frequent yet understudied feature of neurodegenerative spectrum disorders, including Alzheimer’s disease (AD) and Parkinson...
The COVID-19 pandemic has intensified concerns about its long-term neurological impact, with growing evidence linking SARS-CoV-2 infection to neurodeg...
Sleep disturbances have been shown to be intimately and bidirectionally related to disease progression across a wide range of neurodegenerative disord...
Spatial transcriptomics enables the study of how gene expression is organized across tissues, revealing how cells interact within their native microen...
Spatial transcriptomics (ST) is a powerful tool for studying the molecular basis of brain diseases. However, most current analyses focus only on nucle...
Digital language markers show promise in detecting early cognitive impairment related to Alzheimer’s disease (AD), yet their relationship with cerebro...
Accurately predicting gene expression from DNA sequence remains a central challenge in human genetics. Current sequence-based models overlook natural ...
Modern proteins are remarkable polymers built from a 20-amino-acid alphabet, shaped by billions of years of evolution. Yet in Earth’s prebiotic era, s...
Hyaluronan and proteoglycan link protein 2 (HAPLN2) / Brain link protein-1 (Bral1) is important for the binding of chondroitin sulfate proteoglycans (...
Resolving dynamic cellular transitions at single-cell resolution is essential for understanding complex biological processes in development, disease, ...